Management of Cardiac Disease in Cancer Patients Throughout Oncological Treatment: ESMO Consensus Recommendations
Published in 2020 – Ann Oncol (2020); 31(2): 171-190.
Authors: G. Curigliano, D. Lenihan, M. Fradley, S. Ganatra, A. Barac, A. Blaes, J. Herrmann, C. Porter, A. R. Lyon, P. Lancellotti, A. Patel, J. DeCara, J. Mitchell, E. Harrison, J. Moslehi, R. Witteles, M. G. Calabro, R. Orecchia, E. de Azambuja, J. L. Zamorano, R. Krone, Z. Iakobishvili, J. Carver, S. Armenian, B.Ky, D. Cardinale, C. M. Cipolla, S. Dent & K. Jordan
This ESMO consensus manuscript recommends best practices for the care of cancer patients exposed to potential cardiotoxic therapy, including chemotherapeutic agents, targeted therapies and radiotherapy. These guidelines define common cardiovascular toxicities related to anticancer therapy and provide suggested strategies for the prevention, detection and treatment of cardiotoxicity.